Provided by Tiger Trade Technology Pte. Ltd.

Galectin Therapeutics

5.74
-0.5600-8.89%
Post-market: 5.740.00000.00%19:33 EST
Volume:774.14K
Turnover:4.66M
Market Cap:370.07M
PE:-9.72
High:6.66
Open:6.28
Low:5.67
Close:6.30
52wk High:6.66
52wk Low:0.7260
Shares:64.47M
Float Shares:44.93M
Volume Ratio:1.95
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5905
EPS(LYR):-0.7575
ROE:-3727.94%
ROA:-87.09%
PB:-2.94
PE(LYR):-7.58

Loading ...

Galectin Therapeutics Inc.'s (NASDAQ:GALT) market cap up US$42m last week, benefiting both individual investors who own 53% as well as insiders

Simply Wall St.
·
Oct 14

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025

GlobeNewswire
·
Oct 07

Joel Lewis, President and CEO, Reports Disposal of Common Shares in Galectin Therapeutics Inc

Reuters
·
Sep 16

Galectin Therapeutics Inc. Unveils Corporate Presentation on Galectin-Based Therapeutics for Chronic Liver Diseases and Cancer

Reuters
·
Sep 08

Galectin Therapeutics Inc. Unveils Corporate Presentation Highlighting Advancements in Galectin-3 Inhibitors for Liver Diseases and Cancer

Reuters
·
Aug 20

Galectin Therapeutics Q2 EPS $(0.12) Beats $(0.16) Estimate

Benzinga
·
Aug 14

Galectin Therapeutics Q2 Net Income USD -7.521 Million

THOMSON REUTERS
·
Aug 14

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update

GlobeNewswire
·
Aug 14

Galectin Therapeutics Inc: Q2 EPS $-0.12

THOMSON REUTERS
·
Aug 14

Galectin Therapeutics Reports Q2 2025 Net Loss of $7.6M, EPS of ($0.12); Significant Decrease from $12.4M Loss in Q1 2024

Reuters
·
Aug 14

Galectin Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
Aug 09

Director Kary Eldred Reports Acquisition of Galectin Therapeutics Inc. Common Shares

Reuters
·
Jul 22

Director Kevin D. Freeman Reports Acquisition of Common Shares in Galectin Therapeutics Inc

Reuters
·
Jul 18

Galectin Therapeutics Inc. Secures $10 Million Credit Line to Fund Expansion Efforts Through 2026

Reuters
·
Jul 09

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

Reuters
·
Jun 18

BUZZ-H.C. Wainwright starts coverage of Galectin Therapeutics with 'buy'

Reuters
·
Jun 17

Galectin Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Jun 17

Galectin Therapeutics Inc. Presents Promising Results of Belapectin as a Galectin-3 Inhibitor for MASH Cirrhosis and Portal Hypertension

Reuters
·
Jun 17